DRUG · Unmapped registry intervention
LAF237 (vildagliptin)
Find medicine records ·
Find other trials using this name
Clinical trial
Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin
NCT01766778
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Metformin
Normalized identity: metforminView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEarly add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Type-2 Diabetes Mellitusunresolved
Interventions
MetforminDRUG · verified · RxNorm: metformin
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01766778 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.